ExoDx Prostate Evaluation in Active Surveillance Patient Population
Recruiting
- Conditions
- Prostate Cancer
- Registration Number
- NCT05572099
- Lead Sponsor
- Exosome Diagnostics, Inc.
- Brief Summary
The goal of this observational study is to test whether the ExoDx Prostate test add value in biopsy decision making to patients with prostate cancer on an active surveillance regimen.
- Detailed Description
The current trial seeks to evaluate the role of the ExoDx Prostate test in men with low and favorable intermediate prostate cancer undergoing an active surveillance regimen.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 750
Inclusion Criteria
- Male, 45+ years of age diagnosed with low-grade or favorable-intermediate prostate cancer and on an active surveillance regimen
Exclusion Criteria
- Clinical symptoms of urinary tract infection at time of enrollment.
- History of invasive treatment for benign prostatic hypertrophy with in 6 months of enrollment.
- Known hepatitis or HIV
- History of concurrent renal/bladder tumors
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Develop and evaluate risk-based scoring using the ExoDx Prostate test. 1yr after last enrolled patient
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chesapeake Urology
🇺🇸Towson, Maryland, United States